Aintzane
Zabaleta Azpiroz
Investigadora Asociada
Instituto de Investigación Sanitaria de Navarra
Pamplona, EspañaPublications in collaboration with researchers from Instituto de Investigación Sanitaria de Navarra (8)
2021
-
Immunologic characterization of COVID-19 patients with hematological cancer
Haematologica
-
Immunological Biomarkers of Fatal COVID-19: A Study of 868 Patients
Frontiers in Immunology, Vol. 12
2019
-
Daratumumab in combination with urelumab to potentiate anti-myeloma activity in lymphocyte-deficient mice reconstituted with human NK cells
OncoImmunology, Vol. 8, Núm. 7
-
Oncolytic adenovirus Delta-24-RGD induces a widespread glioma proteotype remodeling during autophagy
Journal of Proteomics, Vol. 194, pp. 168-178
-
The mechanism of action of the anti-CD38 monoclonal antibody isatuximab in multiple myeloma
Clinical Cancer Research, Vol. 25, Núm. 10, pp. 3176-3187
2018
-
Spatial and temporal proteome dynamics of glioma cells during oncolytic adenovirus Delta-24-RGD infection
Oncotarget, Vol. 9, Núm. 57, pp. 31045-31065
2016
-
Gene expression analysis during acute hepatitis C virus infection associates dendritic cell activation with viral clearance
Journal of Medical Virology, Vol. 88, Núm. 5, pp. 843-851
2015
-
Clinical testing of a dendritic cell targeted therapeutic vaccine in patients with chronic hepatitis C virus infection
Molecular Therapy - Methods and Clinical Development, Vol. 2, pp. 15006